Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neutropenia 1Neoplasms 1

Interventions

pembrolizumab 134Gemcitabine 101Paclitaxel 100Carboplatin 85Nivolumab 66Docetaxel 62Bevacizumab 62Cisplatin 58Pemetrexed 51Fluorouracil 49Cyclophosphamide 41Cetuximab 41trametinib 38venetoclax 37Leucovorin 37Irinotecan 37Sorafenib 35Capecitabine 35Ipilimumab 33Dexamethasone 32atezolizumab 31Erlotinib Hydrochloride 28130-nm albumin-bound paclitaxel 28Drug Therapy 27Epoetin Alfa 26Doxorubicin 25Oxaliplatin 24Albumin-Bound Paclitaxel 24Prednisone 23Rituximab 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasms × Diet, High-Fat × Clear all
NCT02700360 2016-03-15

Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers

Enzychem Lifesciences Corporation

Phase 1 Completed
36 enrolled

Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡